CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas

R. Appay, C. Dehais, C. Maurage, A. Alentorn, C. Carpentier,  C. Colin, F. Ducray, F. Escande, A. Idbaih , A. Kamoun , Y. Marie , K. Mokhtari, E. Tabouret, N. Trabelsi, E. Uro-Coste, J. Delattre , D. Figarella-Branger, POLA Network